The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Megestrol Acetate (Megace) Market Research Report 2025
Synopsis
The global Megestrol Acetate (Megace) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Megestrol Acetate (Megace) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Megestrol Acetate (Megace) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Megestrol Acetate (Megace) include Par Pharmaceutical (Endo International), Teva Pharmaceuticals, Hikma (West-ward Pharm, Roxane Labs..), TWi Pharmaceuticals, Hi-tech Pharmacal (Akorn), Nanjing Cuccess Pharmaceutical, Xianju pharma, Jiangsu Nhwa Pharmaceutical and Qingdao Guohai Biological Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Megestrol Acetate (Megace), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Megestrol Acetate (Megace).
Report Scope
The Megestrol Acetate (Megace) market size, estimations, and forecasts are provided in terms of sales volume (M Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Megestrol Acetate (Megace) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Megestrol Acetate (Megace) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Par Pharmaceutical (Endo International)
Teva Pharmaceuticals
Hikma (West-ward Pharm, Roxane Labs..)
TWi Pharmaceuticals
Hi-tech Pharmacal (Akorn)
Nanjing Cuccess Pharmaceutical
Xianju pharma
Jiangsu Nhwa Pharmaceutical
Qingdao Guohai Biological Pharmaceutical
Grand Deten Pharmaceutical
Breckenridge Pharmaceutical
Apotex Corporation
Actiza Pharmaceutical
Morton Grove Pharmaceutical
Segment by Type
Suspension
Tablets
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Megestrol Acetate (Megace) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Megestrol Acetate (Megace) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Megestrol Acetate (Megace) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Megestrol Acetate (Megace) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Megestrol Acetate (Megace) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Megestrol Acetate (Megace) include Par Pharmaceutical (Endo International), Teva Pharmaceuticals, Hikma (West-ward Pharm, Roxane Labs..), TWi Pharmaceuticals, Hi-tech Pharmacal (Akorn), Nanjing Cuccess Pharmaceutical, Xianju pharma, Jiangsu Nhwa Pharmaceutical and Qingdao Guohai Biological Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Megestrol Acetate (Megace), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Megestrol Acetate (Megace).
Report Scope
The Megestrol Acetate (Megace) market size, estimations, and forecasts are provided in terms of sales volume (M Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Megestrol Acetate (Megace) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Megestrol Acetate (Megace) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Par Pharmaceutical (Endo International)
Teva Pharmaceuticals
Hikma (West-ward Pharm, Roxane Labs..)
TWi Pharmaceuticals
Hi-tech Pharmacal (Akorn)
Nanjing Cuccess Pharmaceutical
Xianju pharma
Jiangsu Nhwa Pharmaceutical
Qingdao Guohai Biological Pharmaceutical
Grand Deten Pharmaceutical
Breckenridge Pharmaceutical
Apotex Corporation
Actiza Pharmaceutical
Morton Grove Pharmaceutical
Segment by Type
Suspension
Tablets
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Megestrol Acetate (Megace) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Megestrol Acetate (Megace) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Megestrol Acetate (Megace) Market Overview
1.1 Product Overview and Scope of Megestrol Acetate (Megace)
1.2 Megestrol Acetate (Megace) Segment by Type
1.2.1 Global Megestrol Acetate (Megace) Market Value Comparison by Type (2024-2030)
1.2.2 Suspension
1.2.3 Tablets
1.3 Megestrol Acetate (Megace) Segment by Application
1.3.1 Global Megestrol Acetate (Megace) Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Megestrol Acetate (Megace) Market Size Estimates and Forecasts
1.4.1 Global Megestrol Acetate (Megace) Revenue 2019-2030
1.4.2 Global Megestrol Acetate (Megace) Sales 2019-2030
1.4.3 Global Megestrol Acetate (Megace) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Megestrol Acetate (Megace) Market Competition by Manufacturers
2.1 Global Megestrol Acetate (Megace) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Megestrol Acetate (Megace) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Megestrol Acetate (Megace) Average Price by Manufacturers (2019-2024)
2.4 Global Megestrol Acetate (Megace) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Megestrol Acetate (Megace), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Megestrol Acetate (Megace), Product Type & Application
2.7 Megestrol Acetate (Megace) Market Competitive Situation and Trends
2.7.1 Megestrol Acetate (Megace) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Megestrol Acetate (Megace) Players Market Share by Revenue
2.7.3 Global Megestrol Acetate (Megace) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Megestrol Acetate (Megace) Retrospective Market Scenario by Region
3.1 Global Megestrol Acetate (Megace) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Megestrol Acetate (Megace) Global Megestrol Acetate (Megace) Sales by Region: 2019-2030
3.2.1 Global Megestrol Acetate (Megace) Sales by Region: 2019-2024
3.2.2 Global Megestrol Acetate (Megace) Sales by Region: 2025-2030
3.3 Global Megestrol Acetate (Megace) Global Megestrol Acetate (Megace) Revenue by Region: 2019-2030
3.3.1 Global Megestrol Acetate (Megace) Revenue by Region: 2019-2024
3.3.2 Global Megestrol Acetate (Megace) Revenue by Region: 2025-2030
3.4 North America Megestrol Acetate (Megace) Market Facts & Figures by Country
3.4.1 North America Megestrol Acetate (Megace) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Megestrol Acetate (Megace) Sales by Country (2019-2030)
3.4.3 North America Megestrol Acetate (Megace) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Megestrol Acetate (Megace) Market Facts & Figures by Country
3.5.1 Europe Megestrol Acetate (Megace) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Megestrol Acetate (Megace) Sales by Country (2019-2030)
3.5.3 Europe Megestrol Acetate (Megace) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Megestrol Acetate (Megace) Market Facts & Figures by Country
3.6.1 Asia Pacific Megestrol Acetate (Megace) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Megestrol Acetate (Megace) Sales by Country (2019-2030)
3.6.3 Asia Pacific Megestrol Acetate (Megace) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Megestrol Acetate (Megace) Market Facts & Figures by Country
3.7.1 Latin America Megestrol Acetate (Megace) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Megestrol Acetate (Megace) Sales by Country (2019-2030)
3.7.3 Latin America Megestrol Acetate (Megace) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Megestrol Acetate (Megace) Market Facts & Figures by Country
3.8.1 Middle East and Africa Megestrol Acetate (Megace) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Megestrol Acetate (Megace) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Megestrol Acetate (Megace) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Megestrol Acetate (Megace) Sales by Type (2019-2030)
4.1.1 Global Megestrol Acetate (Megace) Sales by Type (2019-2024)
4.1.2 Global Megestrol Acetate (Megace) Sales by Type (2025-2030)
4.1.3 Global Megestrol Acetate (Megace) Sales Market Share by Type (2019-2030)
4.2 Global Megestrol Acetate (Megace) Revenue by Type (2019-2030)
4.2.1 Global Megestrol Acetate (Megace) Revenue by Type (2019-2024)
4.2.2 Global Megestrol Acetate (Megace) Revenue by Type (2025-2030)
4.2.3 Global Megestrol Acetate (Megace) Revenue Market Share by Type (2019-2030)
4.3 Global Megestrol Acetate (Megace) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Megestrol Acetate (Megace) Sales by Application (2019-2030)
5.1.1 Global Megestrol Acetate (Megace) Sales by Application (2019-2024)
5.1.2 Global Megestrol Acetate (Megace) Sales by Application (2025-2030)
5.1.3 Global Megestrol Acetate (Megace) Sales Market Share by Application (2019-2030)
5.2 Global Megestrol Acetate (Megace) Revenue by Application (2019-2030)
5.2.1 Global Megestrol Acetate (Megace) Revenue by Application (2019-2024)
5.2.2 Global Megestrol Acetate (Megace) Revenue by Application (2025-2030)
5.2.3 Global Megestrol Acetate (Megace) Revenue Market Share by Application (2019-2030)
5.3 Global Megestrol Acetate (Megace) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Par Pharmaceutical (Endo International)
6.1.1 Par Pharmaceutical (Endo International) Corporation Information
6.1.2 Par Pharmaceutical (Endo International) Description and Business Overview
6.1.3 Par Pharmaceutical (Endo International) Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Par Pharmaceutical (Endo International) Megestrol Acetate (Megace) Product Portfolio
6.1.5 Par Pharmaceutical (Endo International) Recent Developments/Updates
6.2 Teva Pharmaceuticals
6.2.1 Teva Pharmaceuticals Corporation Information
6.2.2 Teva Pharmaceuticals Description and Business Overview
6.2.3 Teva Pharmaceuticals Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Pharmaceuticals Megestrol Acetate (Megace) Product Portfolio
6.2.5 Teva Pharmaceuticals Recent Developments/Updates
6.3 Hikma (West-ward Pharm, Roxane Labs..)
6.3.1 Hikma (West-ward Pharm, Roxane Labs..) Corporation Information
6.3.2 Hikma (West-ward Pharm, Roxane Labs..) Description and Business Overview
6.3.3 Hikma (West-ward Pharm, Roxane Labs..) Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Hikma (West-ward Pharm, Roxane Labs..) Megestrol Acetate (Megace) Product Portfolio
6.3.5 Hikma (West-ward Pharm, Roxane Labs..) Recent Developments/Updates
6.4 TWi Pharmaceuticals
6.4.1 TWi Pharmaceuticals Corporation Information
6.4.2 TWi Pharmaceuticals Description and Business Overview
6.4.3 TWi Pharmaceuticals Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 TWi Pharmaceuticals Megestrol Acetate (Megace) Product Portfolio
6.4.5 TWi Pharmaceuticals Recent Developments/Updates
6.5 Hi-tech Pharmacal (Akorn)
6.5.1 Hi-tech Pharmacal (Akorn) Corporation Information
6.5.2 Hi-tech Pharmacal (Akorn) Description and Business Overview
6.5.3 Hi-tech Pharmacal (Akorn) Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hi-tech Pharmacal (Akorn) Megestrol Acetate (Megace) Product Portfolio
6.5.5 Hi-tech Pharmacal (Akorn) Recent Developments/Updates
6.6 Nanjing Cuccess Pharmaceutical
6.6.1 Nanjing Cuccess Pharmaceutical Corporation Information
6.6.2 Nanjing Cuccess Pharmaceutical Description and Business Overview
6.6.3 Nanjing Cuccess Pharmaceutical Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Nanjing Cuccess Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
6.6.5 Nanjing Cuccess Pharmaceutical Recent Developments/Updates
6.7 Xianju pharma
6.6.1 Xianju pharma Corporation Information
6.6.2 Xianju pharma Description and Business Overview
6.6.3 Xianju pharma Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Xianju pharma Megestrol Acetate (Megace) Product Portfolio
6.7.5 Xianju pharma Recent Developments/Updates
6.8 Jiangsu Nhwa Pharmaceutical
6.8.1 Jiangsu Nhwa Pharmaceutical Corporation Information
6.8.2 Jiangsu Nhwa Pharmaceutical Description and Business Overview
6.8.3 Jiangsu Nhwa Pharmaceutical Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Jiangsu Nhwa Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
6.8.5 Jiangsu Nhwa Pharmaceutical Recent Developments/Updates
6.9 Qingdao Guohai Biological Pharmaceutical
6.9.1 Qingdao Guohai Biological Pharmaceutical Corporation Information
6.9.2 Qingdao Guohai Biological Pharmaceutical Description and Business Overview
6.9.3 Qingdao Guohai Biological Pharmaceutical Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Qingdao Guohai Biological Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
6.9.5 Qingdao Guohai Biological Pharmaceutical Recent Developments/Updates
6.10 Grand Deten Pharmaceutical
6.10.1 Grand Deten Pharmaceutical Corporation Information
6.10.2 Grand Deten Pharmaceutical Description and Business Overview
6.10.3 Grand Deten Pharmaceutical Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Grand Deten Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
6.10.5 Grand Deten Pharmaceutical Recent Developments/Updates
6.11 Breckenridge Pharmaceutical
6.11.1 Breckenridge Pharmaceutical Corporation Information
6.11.2 Breckenridge Pharmaceutical Megestrol Acetate (Megace) Description and Business Overview
6.11.3 Breckenridge Pharmaceutical Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Breckenridge Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
6.11.5 Breckenridge Pharmaceutical Recent Developments/Updates
6.12 Apotex Corporation
6.12.1 Apotex Corporation Corporation Information
6.12.2 Apotex Corporation Megestrol Acetate (Megace) Description and Business Overview
6.12.3 Apotex Corporation Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Apotex Corporation Megestrol Acetate (Megace) Product Portfolio
6.12.5 Apotex Corporation Recent Developments/Updates
6.13 Actiza Pharmaceutical
6.13.1 Actiza Pharmaceutical Corporation Information
6.13.2 Actiza Pharmaceutical Megestrol Acetate (Megace) Description and Business Overview
6.13.3 Actiza Pharmaceutical Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Actiza Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
6.13.5 Actiza Pharmaceutical Recent Developments/Updates
6.14 Morton Grove Pharmaceutical
6.14.1 Morton Grove Pharmaceutical Corporation Information
6.14.2 Morton Grove Pharmaceutical Megestrol Acetate (Megace) Description and Business Overview
6.14.3 Morton Grove Pharmaceutical Megestrol Acetate (Megace) Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Morton Grove Pharmaceutical Megestrol Acetate (Megace) Product Portfolio
6.14.5 Morton Grove Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Megestrol Acetate (Megace) Industry Chain Analysis
7.2 Megestrol Acetate (Megace) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Megestrol Acetate (Megace) Production Mode & Process
7.4 Megestrol Acetate (Megace) Sales and Marketing
7.4.1 Megestrol Acetate (Megace) Sales Channels
7.4.2 Megestrol Acetate (Megace) Distributors
7.5 Megestrol Acetate (Megace) Customers
8 Megestrol Acetate (Megace) Market Dynamics
8.1 Megestrol Acetate (Megace) Industry Trends
8.2 Megestrol Acetate (Megace) Market Drivers
8.3 Megestrol Acetate (Megace) Market Challenges
8.4 Megestrol Acetate (Megace) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Megestrol Acetate (Megace) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Megestrol Acetate (Megace) Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Megestrol Acetate (Megace) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Megestrol Acetate (Megace) Sales (M Unit) of Key Manufacturers (2019-2024)
Table 5. Global Megestrol Acetate (Megace) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Megestrol Acetate (Megace) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Megestrol Acetate (Megace) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Megestrol Acetate (Megace) Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Megestrol Acetate (Megace), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Megestrol Acetate (Megace), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Megestrol Acetate (Megace), Product Type & Application
Table 12. Global Key Manufacturers of Megestrol Acetate (Megace), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Megestrol Acetate (Megace) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Megestrol Acetate (Megace) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Megestrol Acetate (Megace) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Megestrol Acetate (Megace) Sales by Region (2019-2024) & (M Unit)
Table 18. Global Megestrol Acetate (Megace) Sales Market Share by Region (2019-2024)
Table 19. Global Megestrol Acetate (Megace) Sales by Region (2025-2030) & (M Unit)
Table 20. Global Megestrol Acetate (Megace) Sales Market Share by Region (2025-2030)
Table 21. Global Megestrol Acetate (Megace) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Megestrol Acetate (Megace) Revenue Market Share by Region (2019-2024)
Table 23. Global Megestrol Acetate (Megace) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Megestrol Acetate (Megace) Revenue Market Share by Region (2025-2030)
Table 25. North America Megestrol Acetate (Megace) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Megestrol Acetate (Megace) Sales by Country (2019-2024) & (M Unit)
Table 27. North America Megestrol Acetate (Megace) Sales by Country (2025-2030) & (M Unit)
Table 28. North America Megestrol Acetate (Megace) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Megestrol Acetate (Megace) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Megestrol Acetate (Megace) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Megestrol Acetate (Megace) Sales by Country (2019-2024) & (M Unit)
Table 32. Europe Megestrol Acetate (Megace) Sales by Country (2025-2030) & (M Unit)
Table 33. Europe Megestrol Acetate (Megace) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Megestrol Acetate (Megace) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Megestrol Acetate (Megace) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Megestrol Acetate (Megace) Sales by Region (2019-2024) & (M Unit)
Table 37. Asia Pacific Megestrol Acetate (Megace) Sales by Region (2025-2030) & (M Unit)
Table 38. Asia Pacific Megestrol Acetate (Megace) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Megestrol Acetate (Megace) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Megestrol Acetate (Megace) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Megestrol Acetate (Megace) Sales by Country (2019-2024) & (M Unit)
Table 42. Latin America Megestrol Acetate (Megace) Sales by Country (2025-2030) & (M Unit)
Table 43. Latin America Megestrol Acetate (Megace) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Megestrol Acetate (Megace) Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Megestrol Acetate (Megace) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Megestrol Acetate (Megace) Sales by Country (2019-2024) & (M Unit)
Table 47. Middle East & Africa Megestrol Acetate (Megace) Sales by Country (2025-2030) & (M Unit)
Table 48. Middle East & Africa Megestrol Acetate (Megace) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Megestrol Acetate (Megace) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Megestrol Acetate (Megace) Sales (M Unit) by Type (2019-2024)
Table 51. Global Megestrol Acetate (Megace) Sales (M Unit) by Type (2025-2030)
Table 52. Global Megestrol Acetate (Megace) Sales Market Share by Type (2019-2024)
Table 53. Global Megestrol Acetate (Megace) Sales Market Share by Type (2025-2030)
Table 54. Global Megestrol Acetate (Megace) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Megestrol Acetate (Megace) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Megestrol Acetate (Megace) Revenue Market Share by Type (2019-2024)
Table 57. Global Megestrol Acetate (Megace) Revenue Market Share by Type (2025-2030)
Table 58. Global Megestrol Acetate (Megace) Price (USD/Unit) by Type (2019-2024)
Table 59. Global Megestrol Acetate (Megace) Price (USD/Unit) by Type (2025-2030)
Table 60. Global Megestrol Acetate (Megace) Sales (M Unit) by Application (2019-2024)
Table 61. Global Megestrol Acetate (Megace) Sales (M Unit) by Application (2025-2030)
Table 62. Global Megestrol Acetate (Megace) Sales Market Share by Application (2019-2024)
Table 63. Global Megestrol Acetate (Megace) Sales Market Share by Application (2025-2030)
Table 64. Global Megestrol Acetate (Megace) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Megestrol Acetate (Megace) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Megestrol Acetate (Megace) Revenue Market Share by Application (2019-2024)
Table 67. Global Megestrol Acetate (Megace) Revenue Market Share by Application (2025-2030)
Table 68. Global Megestrol Acetate (Megace) Price (USD/Unit) by Application (2019-2024)
Table 69. Global Megestrol Acetate (Megace) Price (USD/Unit) by Application (2025-2030)
Table 70. Par Pharmaceutical (Endo International) Corporation Information
Table 71. Par Pharmaceutical (Endo International) Description and Business Overview
Table 72. Par Pharmaceutical (Endo International) Megestrol Acetate (Megace) Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Par Pharmaceutical (Endo International) Megestrol Acetate (Megace) Product
Table 74. Par Pharmaceutical (Endo International) Recent Developments/Updates
Table 75. Teva Pharmaceuticals Corporation Information
Table 76. Teva Pharmaceuticals Description and Business Overview
Table 77. Teva Pharmaceuticals Megestrol Acetate (Megace) Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Teva Pharmaceuticals Megestrol Acetate (Megace) Product
Table 79. Teva Pharmaceuticals Recent Developments/Updates
Table 80. Hikma (West-ward Pharm, Roxane Labs..) Corporation Information
Table 81. Hikma (West-ward Pharm, Roxane Labs..) Description and Business Overview
Table 82. Hikma (West-ward Pharm, Roxane Labs..) Megestrol Acetate (Megace) Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Hikma (West-ward Pharm, Roxane Labs..) Megestrol Acetate (Megace) Product
Table 84. Hikma (West-ward Pharm, Roxane Labs..) Recent Developments/Updates
Table 85. TWi Pharmaceuticals Corporation Information
Table 86. TWi Pharmaceuticals Description and Business Overview
Table 87. TWi Pharmaceuticals Megestrol Acetate (Megace) Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. TWi Pharmaceuticals Megestrol Acetate (Megace) Product
Table 89. TWi Pharmaceuticals Recent Developments/Updates
Table 90. Hi-tech Pharmacal (Akorn) Corporation Information
Table 91. Hi-tech Pharmacal (Akorn) Description and Business Overview
Table 92. Hi-tech Pharmacal (Akorn) Megestrol Acetate (Megace) Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Hi-tech Pharmacal (Akorn) Megestrol Acetate (Megace) Product
Table 94. Hi-tech Pharmacal (Akorn) Recent Developments/Updates
Table 95. Nanjing Cuccess Pharmaceutical Corporation Information
Table 96. Nanjing Cuccess Pharmaceutical Description and Business Overview
Table 97. Nanjing Cuccess Pharmaceutical Megestrol Acetate (Megace) Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Nanjing Cuccess Pharmaceutical Megestrol Acetate (Megace) Product
Table 99. Nanjing Cuccess Pharmaceutical Recent Developments/Updates
Table 100. Xianju pharma Corporation Information
Table 101. Xianju pharma Description and Business Overview
Table 102. Xianju pharma Megestrol Acetate (Megace) Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Xianju pharma Megestrol Acetate (Megace) Product
Table 104. Xianju pharma Recent Developments/Updates
Table 105. Jiangsu Nhwa Pharmaceutical Corporation Information
Table 106. Jiangsu Nhwa Pharmaceutical Description and Business Overview
Table 107. Jiangsu Nhwa Pharmaceutical Megestrol Acetate (Megace) Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Jiangsu Nhwa Pharmaceutical Megestrol Acetate (Megace) Product
Table 109. Jiangsu Nhwa Pharmaceutical Recent Developments/Updates
Table 110. Qingdao Guohai Biological Pharmaceutical Corporation Information
Table 111. Qingdao Guohai Biological Pharmaceutical Description and Business Overview
Table 112. Qingdao Guohai Biological Pharmaceutical Megestrol Acetate (Megace) Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Qingdao Guohai Biological Pharmaceutical Megestrol Acetate (Megace) Product
Table 114. Qingdao Guohai Biological Pharmaceutical Recent Developments/Updates
Table 115. Grand Deten Pharmaceutical Corporation Information
Table 116. Grand Deten Pharmaceutical Description and Business Overview
Table 117. Grand Deten Pharmaceutical Megestrol Acetate (Megace) Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Grand Deten Pharmaceutical Megestrol Acetate (Megace) Product
Table 119. Grand Deten Pharmaceutical Recent Developments/Updates
Table 120. Breckenridge Pharmaceutical Corporation Information
Table 121. Breckenridge Pharmaceutical Description and Business Overview
Table 122. Breckenridge Pharmaceutical Megestrol Acetate (Megace) Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Breckenridge Pharmaceutical Megestrol Acetate (Megace) Product
Table 124. Breckenridge Pharmaceutical Recent Developments/Updates
Table 125. Apotex Corporation Corporation Information
Table 126. Apotex Corporation Description and Business Overview
Table 127. Apotex Corporation Megestrol Acetate (Megace) Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Apotex Corporation Megestrol Acetate (Megace) Product
Table 129. Apotex Corporation Recent Developments/Updates
Table 130. Actiza Pharmaceutical Corporation Information
Table 131. Actiza Pharmaceutical Description and Business Overview
Table 132. Actiza Pharmaceutical Megestrol Acetate (Megace) Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Actiza Pharmaceutical Megestrol Acetate (Megace) Product
Table 134. Actiza Pharmaceutical Recent Developments/Updates
Table 135. Morton Grove Pharmaceutical Corporation Information
Table 136. Morton Grove Pharmaceutical Description and Business Overview
Table 137. Morton Grove Pharmaceutical Megestrol Acetate (Megace) Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Morton Grove Pharmaceutical Megestrol Acetate (Megace) Product
Table 139. Morton Grove Pharmaceutical Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Megestrol Acetate (Megace) Distributors List
Table 143. Megestrol Acetate (Megace) Customers List
Table 144. Megestrol Acetate (Megace) Market Trends
Table 145. Megestrol Acetate (Megace) Market Drivers
Table 146. Megestrol Acetate (Megace) Market Challenges
Table 147. Megestrol Acetate (Megace) Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Megestrol Acetate (Megace)
Figure 2. Global Megestrol Acetate (Megace) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Megestrol Acetate (Megace) Market Share by Type in 2023 & 2030
Figure 4. Suspension Product Picture
Figure 5. Tablets Product Picture
Figure 6. Global Megestrol Acetate (Megace) Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Megestrol Acetate (Megace) Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Megestrol Acetate (Megace) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Megestrol Acetate (Megace) Market Size (2019-2030) & (US$ Million)
Figure 13. Global Megestrol Acetate (Megace) Sales (2019-2030) & (M Unit)
Figure 14. Global Megestrol Acetate (Megace) Average Price (USD/Unit) & (2019-2030)
Figure 15. Megestrol Acetate (Megace) Report Years Considered
Figure 16. Megestrol Acetate (Megace) Sales Share by Manufacturers in 2023
Figure 17. Global Megestrol Acetate (Megace) Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Megestrol Acetate (Megace) Players: Market Share by Revenue in 2023
Figure 19. Megestrol Acetate (Megace) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Megestrol Acetate (Megace) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Megestrol Acetate (Megace) Sales Market Share by Country (2019-2030)
Figure 22. North America Megestrol Acetate (Megace) Revenue Market Share by Country (2019-2030)
Figure 23. United States Megestrol Acetate (Megace) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Megestrol Acetate (Megace) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Megestrol Acetate (Megace) Sales Market Share by Country (2019-2030)
Figure 26. Europe Megestrol Acetate (Megace) Revenue Market Share by Country (2019-2030)
Figure 27. Germany Megestrol Acetate (Megace) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Megestrol Acetate (Megace) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Megestrol Acetate (Megace) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Megestrol Acetate (Megace) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Megestrol Acetate (Megace) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Megestrol Acetate (Megace) Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Megestrol Acetate (Megace) Revenue Market Share by Region (2019-2030)
Figure 34. China Megestrol Acetate (Megace) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Megestrol Acetate (Megace) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Megestrol Acetate (Megace) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Megestrol Acetate (Megace) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Megestrol Acetate (Megace) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Megestrol Acetate (Megace) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Megestrol Acetate (Megace) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Megestrol Acetate (Megace) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Megestrol Acetate (Megace) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Megestrol Acetate (Megace) Sales Market Share by Country (2019-2030)
Figure 44. Latin America Megestrol Acetate (Megace) Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Megestrol Acetate (Megace) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Megestrol Acetate (Megace) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Megestrol Acetate (Megace) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Megestrol Acetate (Megace) Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Megestrol Acetate (Megace) Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Megestrol Acetate (Megace) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Megestrol Acetate (Megace) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Megestrol Acetate (Megace) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Megestrol Acetate (Megace) by Type (2019-2030)
Figure 54. Global Revenue Market Share of Megestrol Acetate (Megace) by Type (2019-2030)
Figure 55. Global Megestrol Acetate (Megace) Price (USD/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Megestrol Acetate (Megace) by Application (2019-2030)
Figure 57. Global Revenue Market Share of Megestrol Acetate (Megace) by Application (2019-2030)
Figure 58. Global Megestrol Acetate (Megace) Price (USD/Unit) by Application (2019-2030)
Figure 59. Megestrol Acetate (Megace) Value Chain
Figure 60. Megestrol Acetate (Megace) Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
